ArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio

Wednesday, May 15, 2019

BOULDER, Colo., May, 15, 2019 /PRNEWSWIRE/-- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, today announced the closing of an up to $60 million Series B financing round led by Perceptive Advisors. The investor syndicate also includes existing investors PBM Capital, Boulder Ventures, Longwood Fund and Peierls Foundation.  

AdvaMed President and CEO Releases Statement On the House Bill To Repeal the Medical Device Tax

Thursday, April 11, 2019

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (H.R. 2207) in the U.S. House of Representatives to permanently repeal the medical device excise tax:

“America’s medical technology industry is facing a $20 billion tax increase at year-end, when the current medical device tax suspension expires. Urgent action is essential to protect future medtech innovations that benefit patients and to avoid putting good-paying U.S. jobs at risk.

“House introduction today of the ‘Protect Medical Innovation Act of 2019’ in the 116th Congress brings us one step closer to ensuring this innovation-stifling burden on the medtech industry never returns, supporting continued American leadership of this vital industry.

“We thank the bill’s lead sponsors, Reps. Ron Kind (D-Wis.), Jackie Walorski (R-Ind.), Scott Peters (D-Calif.), and Richard Hudson (R-N.C.) for their leadership on this issue. This bill – and the strong bipartisan support they have gathered – reflect the high priority this Congress places on patients, jobs, and future investment.

“While past suspensions of the medical device tax have enabled manufacturers to invest in R&D, infrastructure and new hiring – which in turn benefits patients and the U.S. economy – these benefits are at risk. Now that bipartisan legislation to permanently repeal the device tax has been introduced in both the House and Senate, AdvaMed will urge Congress and the administration to act as expeditiously as possible to get rid of the tax once and for all this year.”

Continue Reading

Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M

Monday, April 08, 2019

Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new funding adds to the $85.5 million financing Inscripta announced in 2018, bringing the total raised for the round to $105.5 million. 

CBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology

Thursday, April 04, 2019

Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science 
Continue Reading

Colorado BioScience Association Applauds Expansion by Novartis Company AveXis to Longmont

Monday, April 01, 2019

April 1, 2019

Colorado BioScience Association Explores New Possibilities for Medtech at Annual Symposium

Monday, March 04, 2019

Medical device industry leaders to focus on blockchain technology, M&A trends and federal policy 
Continue Reading

Colorado BioScience Association connects lawmakers to patient-focused innovators at Capitol event

Tuesday, February 19, 2019

New results highlight success of state-funded grant program for early-stage life science companies
Continue Reading

Colorado BioScience Association Appoints Emily Roberts as New Vice President

Monday, February 04, 2019

Roberts to Oversee Policy and Communications at Life Science Organization 
Continue Reading

Colorado Bioscience Companies Raised $1 Billion in 2018

Thursday, December 27, 2018

International Investors Contributed to the State’s Largest Financings 
Continue Reading

Colorado BioScience Association Appoints Jennifer Jones Paton as New President and Chief Executive Officer

Thursday, November 08, 2018

Jones Paton Promoted to Lead Life Science Organization After Broad Search 
Continue Reading